ACS Chemical Neuroscience · 2012 · 56 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationLigand BindingLigand-based DesignMolecular DockingPotency OptimizationSerotonergic PharmacologyStructure-activity Relationship Analysis5-Hydroxytryptamine Receptor PharmacologyLigand Conformation MappingReceptor-ligand BindingSelectivitySerotonergic Drug DiscoverySerotonergic Ligand DesignSerotonin Receptor PharmacologyStructure-based Ligand Design
Based on the structure of the superpotent 5-HT(2A) agonist 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, which consists of a ring-substituted phenethylamine skeleton modified with an N-benzyl group, we designed and synthesized a small library of constrained analogues to identify the optimal arrangement of the pharmacophoric elements of the ligand. Structures consisted of diversely substituted tetrahydroisoquinolines, piperidines, and one benzazepine. Based on the structure of (S,S)-9b, which showed the highest affinity of the series, we propose an optimal binding conformation. (S,S)-9b also displayed 124-fold selectivity for the 5-HT(2A) over the 5-HT(2C) receptor, making it the most selective 5-HT(2A) receptor agonist ligand currently known.
17
Deborah Kurrasch‐Orbaugh, Val J. Watts, Eric L. Barker et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 165 citations
Charlotta Mellin, Jerk Vallgaarda, David L. Nelson et al. · Journal of Medicinal Chemistry · 1991 · 64 citations · Full text